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Introduction
The issue of supremacy between state and federal powers was of paramount
importance to the drafters of the United States Constitution. The founding fathers stress
the importance of supremacy several times in the Federalist Papers. Alexander Hamilton
writes, “Law, by the very meaning of the term includes supremacy.”1 Hamilton goes on
to argue that when smaller political societies form a larger government together, the
larger encompassing government must be supreme or It would just be a mere treaty
between small political societies. For these reasons, the founding fathers created Clause 2
in Article VI of the Constitution. Known less formally as the Supremacy Clause, it states,
“This Constitution, and the Laws of the United States which shall be made in
pursuance thereof; and all treaties made, or which shall be made, under the
authority of the United States, shall be the supreme law of the land; and the judges
in every state shall be bound thereby, anything in the constitution or laws of any
state to the contrary notwithstanding.”2
This clause affirms that all federal statutes, treaties, and constitutional powers
shall have supremacy over state laws, and all state judges, must recognize this
supremacy. The Supremacy Clause is forthright in its intentions and the courts, on many
occasions, have used it to rule that federal law is preemptive over state law. In addition,
state judges must adhere to federal laws. Examples of the courts ruling in favor of federal
supremacy include Ware v. Hylton, McCulloch v. Maryland, and Martin v. Hunter's
Lessee. At first glance, the Supremacy Clause appears to offer a clear mandate, from
1
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which conflict should not arise, but the historical record suggests that this is not always
the case.
There are many areas of government concerning individual rights that have
traditionally fallen under the realm of state power, including institutions of health care
and crime. After the Civil War, the Judiciary Branch permitted the federal government to
extend its oversight into in such areas.
However, decades of federal regulation were contested when the Supreme Court
blocked congressional power through the Commerce Clause in the monumental case,
United States v. Lopez. The Commerce Clause creates several ambiguities surrounding
the federal government’s scope of legislation and has important implications for the
legality of medical marijuana.
When Federal authority is only partially preemptive over state law, conflict arises.
This has been the case for laws regarding medical marijuana. Some states, through voter
initiatives, have used this power vacuum to legalize marijuana for medical purposes.
Cannabis, even for medical purposes, is considered a Schedule I drug under the
Controlled Substances Act, and its use is not permitted by the federal government.
After many court battles and years of litigation and regulation, the federal
government is still contesting the medical marijuana industry, which it equates to drug
trafficking. This climate has led to a series of complicated legal cases and has left many
federal, state, and local officials in a position of confusion.

iii

Problems within the legal grey area occur when government officials and agencies, at
both the state and local level, are tasked with managing the business aspect of medical
marijuana dispensaries and are subsequently pressured to follow federal laws or risk
felony persecution. These aspects include zoning, licensing, and tax disputes that have
left many puzzled. This situation has turned into a legal battle that has left extremely ill
patients with semi-legal medication. Patients and providers are constantly at risk of
federal prosecution. Such prosecution is often subject to the discretion of individuals in
the federal government with the cooperation of state and local officials. This legal grey
zone has exposed government policy inconsistencies; while activists for and against
medical marijuana wait for an end to the ambiguity.
For the purpose of exploring and understanding the conflict between state and federal
supremacy, this paper will examine the complications that have arisen with the
implementation of these laws. This piece will critically analyze what is currently
happening to people caught in the legal crossfire and will ultimately propose a series of
solutions to resolve the current impasse.

Chapter 1
The Chronic Problem: A Legal History of Medical Marijuana

Although the federal government currently prohibits the possession and
distribution of marijuana, this was not always the case. In 1611, marijuana was brought
into the colonies by Jamestown settlers for hemp cultivation, and hemp remained a major
industry in the United States until the Civil War. 1 It is estimated that around 75 tons of
hemp were produced in the United States in 1850.2 In the 1840’s physicians used
marijuana as medication to help patients with various illnesses, leading to its official
recognition as medicine in the United States Pharmacopeia from the years 1850 to 1941.3
Cannabis was removed from the pharmacopeia after 1941 not because of its
ineffectiveness as a medicine, but as a result of two events that greatly diminished its
practicality as a medicine. The first was the development of other medications such as
aspirin, morphine, and ten other opium derived drugs which treated pain and other
medicinal needs.4 The second was that the federal government began to regulate its use.

The federal government had not yet outlawed marijuana. Ironically, states were
the first to officially criminalize medical and non-medical marijuana. This is the complete
1
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opposite of the present day situation where on November 6 2012, Colorado and
Washington voted to legalize the sale of non-medical marijuana. When these two states
voted to repeal their marijuana prohibition laws, they are reversing the exact legal path
marijuana prohibition traveled, that is, prohibition at the state level before the federal
level.

State drug prohibition policies began a couple decades after the Civil War when
opium and morphine were abundant and around one percent of the population was
addicted to a pain killer due to over-prescription.

Narcotic regulation began in 1877 when Nevada enacted the first law prohibiting
the sale of any non-medical opiates.5 Twenty-nine states enacted similar narcotic
regulation, the last being in 1914.6 It is important to note that nearly all of these measures
were aimed at distribution rather than consumption.

Drugs were first officially regulated by the Federal government when congress
enacted the 1906 Pure Food and Drug Act. This act, among many other things, required
labels on containing any of ten items which the federal government considered as
“dangerous” substances. On this list was alcohol, morphine, opiates, and cannabis.
Furthermore, this act gave federal authorities the power to confiscate and destroy noncompliant products. It is important to note that this act did not limit or prevent the
purchase any of these drugs. Rather, this legislation was merely aimed to inform people
of the dangers of addictive drugs in their products. The first federal legislation that
5
6
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actually restricted narcotics was the 1909 Act to Prohibit Importation and Use of Opium.
This act restricted opium importation to specific ports, limited the use of opium to
medicinal use, and called for diligent record keeping for opium importation.

As anti-narcotic measures grew in popularity, so did pressure for federal
legislation regarding other drugs considered problematic at the time. The Harrison Act of
1914 required legitimate handlers of cocaine, opium, or other derivatives to file returns
on the importation or exportation of these substances. 7 Registration with the federal
authorities was required to obtain the necessary forms and the penalty for failing to
register was a fine of up to $2,000 and a maximum sentence of five years in jail.

This act is important because for the first time, the federal government established
a group of harmful drugs labeled as narcotics to supervise and regulate. As a result, this
act created the first black market for drugs in United States history and ultimately
contributed to the growth of drug related criminal activities.

In 1920, the Federal government established an agency to enforce drug regulation
policies. This agency was called the Narcotics Division and became part of the
Prohibition Unit of the Internal Revenue Service until it was transferred to the Prohibition
Bureau that was created in 1927.8 In 1930 it was removed from the Prohibition Bureau
and was re-established as the Federal Bureau of Narcotics (FBN) under the Treasury
Department.9 Here it assumed enforcement of the Narcotic Drugs Import and Export Act
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of 1922, the Marijuana Tax Act of 1937, and the Opium Poppy Control Act of 1942. 10
The FBN worked with local government agencies to undermine drug trafficking
activities. In 1968 the FBN merged with the Bureau of Drug Abuse Control to form an
agency called the Bureau of Narcotics and Dangerous Drugs. This was eventually merged
with other agencies to form the Drug Enforcement Agency (DEA) in 1973. This merging
was part of the Reorganization Plan No. 2 signed by Richard Nixon following his
promises to strengthen the federal government’s war on drugs.

Marijuana was first regulated at the state level beginning with Utah’s adoption of
a statute to prohibit the sale or possession of marijuana in 1915. Twenty-two other states
joined in the prohibition by 1931.11 About a decade before marijuana had become a
matter of national debate, the majority of states had enacted marijuana legislation.
Concern over this drug was partially a result of the increasing influence of the Mexican
laborers who often smoked marijuana after long days of working in the field. 12
Mexicans were immigrating to the United States in increasing numbers as laborers, and
began to constitute a significant portion of the population. Nearly all of the marijuana
legislation passed by states contained references to the Mexican origin of the drug and the
criminal conduct it inevitably generated.13 Consequently, sixteen of the twenty-two states
that passed legislation regarding marijuana were in the southern or western portions of
the United States.14

10
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Marijuana started to receive more attention as it was regarded by some as
“Mexican opium.”15 This increased publicity raised concerns that marijuana would
become a substitute for alcohol or opium which had both been banned.

Sensationalist reporting on the violent criminal nature of marijuana addicts
resulted in its confiscation. It was mentioned as a “habit forming drug” in many
instances.16 The momentum of popular opinion grew, and public pressure mounted to
regulate the “loco-weed.” 17 Marijuana was included in the Uniform State Narcotic Drug
Act of 1934, where “states wishing to regulate sale and possession of marijuana [were]
instructed to add cannabis to the definition of narcotic drugs.”18

It wasn’t until the Marihuana Tax Act of 1937 that marijuana was officially
regulated at the federal level. This act imposed registration requirements as well as taxes
on growers, sellers and buyers of marijuana. It is important to note that federal law still
allowed pharmacists to prescribe marijuana, but the passage of this act restricted its use
as a medication by making its prescription and use as a medication impractical for many
physicians. This is primarily due to the paperwork and fees associated with the annual
licensing. In addition to these burdens, the medication was taxed at every level from
production to distribution. The passage of this act received considerable criticism from
the medical community, most notably from Dr. William C. Woodward who served on the
legislative counsel of the American Medical Association. Dr. Woodward criticized the
15
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act because it discouraged the medical profession and pharmacologists from developing
this drug or conducting further research as they see fit.19 It also limited physicians’ ability
to control the non-medical use of marijuana.20 By 1941, the majority of marijuana
products had disappeared, and almost a century of marijuana in the medical industry had
come to an end. After the Marihuana Tax Act, federal regulation of marijuana wasn’t
altered until the Controlled Substance Act of 1970. With the passage of this act, medical
marijuana was no longer just discouraged through overburdening taxes, but it became
outright prohibited from any medicinal use.

One cause for the movement by Congress to pass new legislation was a growing
concern that drugs use among high school and university students was rising. President
Nixon asked congress to enact legislation to stop the rising levels of drug use. In 1970
congress enacted the Controlled Substance Act. The Act separated drugs into categories
based on current medical use and potential for abuse.

Drugs that had no current medical use and were thought to have high potential for
abuse were placed into a category titled schedule I. In this category marijuana, heroin,
LSD, peyote and psilocybin were placed. Then there are the other categories titled
Schedule II-V. These categories contain all the drugs that the federal government
recognizes as having a medical use. Drugs are placed into the schedule categories in
descending order by potential for abuse, with Schedule II having the highest potential and

19
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Schedule V having the lowest. In these categories are opium, cocaine, and
amphetamines.

The decision to schedule marijuana with heroin and other very dangerous drugs
with no medicinal value was highly controversial because it subjected those who used
marijuana medicinally to potential federal prosecution.21 Another issue with the Schedule
I category that many in the scientific community took issue with was that this new
regulation of drugs in Schedule I would impede research. Many people felt that the
placement of marijuana into Schedule I would prevent the research necessary to prove its
medical value. Proponents of medical marijuana feared that its placement in Schedule I
would prevent it from being rescheduled in the future.22

In 1972, citizens upset with the new scheduling system, submitted a petition to the
Bureau of Narcotics and Dangerous Drugs (BNDD). This petition asked the federal
government to reschedule marijuana so people who need it for medical purposes could
access it through prescription.23 The petition was promptly rejected resulting in twentytwo years of court battles until February 18, 1994 when the U.S Court of Appeals D.C
circuit upheld that marijuana would be Schedule I. 24

In 1975, three years after the petition was submitted, a person suffering from
glaucoma named Robert Randall was arrested for cultivating his own cannabis. Despite
the federal stance that marijuana is Schedule I and is not recognized as having any
21
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medicinal value, Robert won his case on the basis of medical necessity. This victory was
significant because it was the first time that the common law concept of necessity was
applied to a medical condition, and because it contested the federal position that
marijuana cannot serve a medical purpose.

The Federal government’s stance was also weakened when the National
Commission on Marihuana and Drug Abuse published a final report stating that scientific
and medical research indicated that previous reports on the harmfulness of marijuana
were exaggerated.25 Both of these events prompted the federal government to open up an
Individual Patient Investigation New Drug (IND) program under the FDA in 1978 to
explore the medicinal benefits of marijuana.26

The program gave participating physicians the ability to prescribe marijuana to
enrolled patients. The program was intended to be a trial program in which patients
would receive marijuana grown under the supervision of the federal government on a trial
basis, as long as strict scientific protocols were followed. This program did create a
legitimate opportunity for patients to obtain marijuana for medicinal purposes but it was
extremely difficult for patients to enroll. Very few patients were accepted into this
program. In the subsequent 14 years that followed, less than 100 people were admitted
into the program for various ailments. The program received a spike of applications in
1992 from AIDS patients seeking to reverse the wasting disease with marijuana. The

25
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program was shut down by the George H. W. Bush Administration shortly after this
increase in applicants.

In the year 1988, after several years of the federal government treating patients
with medical marijuana through the IND program, the chief administrative law judge of
the Drug Enforcement Administration (successor agency of the BNDD), Francis L.
Young, ruled to have marijuana changed to Schedule II.27 This ruling was a response to
the 1972 petition and the many appeals and court proceedings that followed it. After
several public hearings on the medicinal value of marijuana Judge Young wrote:

The evidence in this record clearly shows that marijuana has been
accepted as capable of relieving the distress of great numbers of very ill people,
and doing so with safety under medical supervision. It would be unreasonable,
arbitrary and capricious for the DEA to continue to stand between those sufferers
and the benefits of this substance in light of the evidence in this record. 28

Young’s position was rejected by the administrator of the DEA who reasoned that
marijuana has not been suitably demonstrated as a medicine.29 Another citizen made an
attempt at rescheduling in 1995 with a petition submitted to the DEA. The DEA
consulted the Department of Health and Human Services (HHS) for an evaluation of
marijuana’s potential for abuse and for a recommendation concerning its scheduling. The
HHS found there was a high potential for abuse and that there was no recognized safe

27

Eddy, Medical Marijuana: Review, 9.
Ibid.
29
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medical use, even under supervision.30 On March 20, 2001, the DEA sent a letter to the
petitioner informing him of the petition rejection.

Judge Young was not alone in predicting a change in federal policy regarding
medical marijuana. Many states began to pass their own legislation in the 1970’s. A total
of thirty-one states and the District of Columbia passed legislation involving medical
marijuana.31 The majority of this legislation involved the creation of TRP programs that
were similar to the federal IND programs that authorized clinical trials. The legislation
was written so that the TRP programs, like the IND programs, would be funded by NIDA
(National Institute on Drug Abuse).32 Twenty-two states passed this legislation but
federal oversight only allowed for eight to function. Meanwhile six states went even
further by rescheduling marijuana to Schedule II in their own state schedules. This would
have enabled physicians to prescribe marijuana to patients that qualified, except that the
federal government was still responsible for the distribution of licenses for prescriptions
and medications.33

Over the next several years, state legislation concerning medical marijuana was
halted because of numerous court battles and the introduction of Marinol, an FDA

30
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approved oral capsule containing delta-9-tetrahydrocannbinol (THC).34 THC is the active
ingredient in marijuana that some physicians believe has medicinal value.

This was satisfactory for some advocates but over time many patients who took
this drug were not able to use it properly. This drug is prescribed for nausea associated
with AIDS or to alleviate the side effects of chemotherapy treatment for cancer patients.
Patients found the pill less effective than vaporized or smoked marijuana because
Marinol was often accidentally purged before it could take effect. The problems
associated with Marinol became widely publicized in the mid 1990’s while evidence was
emerging on the positive medicinal effect from smoked marijuana. This brought about
the introduction of new legislation. In 1996, California began a movement that defied the
federal stance on marijuana when California voters passed Proposition 215. Today,
eighteen states and the District of Columbia have passed similar initiatives that legalize
medical marijuana.35 This has caused a series of legal cases involving local, state, federal,
and individual rights where supremacy has been defined by court cases.

The legalization of medical marijuana at the state level and the court cases that
have ensued has created some confusion about the legal status of medical marijuana. It
has also raised questions over federal, state, and local supremacy. In the context of
medical marijuana, the preemptive power of the federal government has been limited in a
unique way. The next chapter will analyze these developments and their significance.

34
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Chapter 2
Blitzed: Lopez Topples the Expansion of Federal Power
In November 1996, Californians passed Proposition 215 also known as the
Compassionate Use Act of 1996. This legislation was historic because for the first time a
state had defied the federal government’s policy on a controlled substance. The state
legalized, for medical purposes, a substance recognized by the Controlled Substance Act
of 1970 as having no medical purposes. Californian’s passed Proposition 215 with three
intentions. The first was to permit seriously ill Californians to obtain and use marijuana
for medicinal purposes. The second was to prevent patients who obtained and used
medical marijuana from being prosecuted as criminals. The last was to encourage the
implementation of a plan by state and federal governments to aid in the safe distribution
of marijuana to all patients who need it.1 Despite the best intentions of California voters
to help seriously ill patients, the federal government viewed the passage of this law as a
shortcut attempt to legalize marijuana. The federal government could have permitted the
passage of this law and worked with state and local authorities to safely implement it.
Instead the federal government has chosen to use every legal option available to resist the
law’s implementation.
The federal government has many ways to do this because there are many points
of legal conflict between this state law and the federal law. The main conflict being that
1

Alistair Newbern, “Good Cop, Bad Cop: Federal Prosecution of State-Legalized Medical Marijuana Use
after United States v. Lopez,” California Law Review 88, no. 5(2000), 1576.
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marijuana still remains Schedule I under federal law with no recognized medicinal use.
Use, distribution or possession of any Schedule I drug subjects individuals to federal
prosecution, unless the individuals are sanctioned under an FDA study.2
Federal officials recognize that resources are too limited to pursue individual
cases, but they have taken alternative measures to prevent the safe application of these
laws. One method is to suspend the licenses of physicians who prescribe medical
marijuana to their patients. Since physician licenses are federally regulated this is a viable
option.
Another way for the federal government to disrupt state medical marijuana laws is
to deny participating physicians Medicaid funding. Both of these options are powerful
methods to disrupt the operation of these laws. These methods have recently become less
realistic because of the many more states that have passed medical marijuana laws. Eight
other states had enacted similar legislation by 2000. The passage of these medical
marijuana laws in some cases has been met with resistance. In one case, the results of the
initiative vote had to eventually be released by court order.3
The federal government has used the Commerce Clause and the CSA to establish
authority over states and their legislation regarding marijuana. The federal government
over the years has been able to rely on the commerce clause a source of its authority
because the Courts have permitted the expansion of the federal view of what is commerce
related. The Commerce Clause is the primary reason for the expansion of the federal
government’s power over the last half a century.
2
3
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There has especially been a very large increase in criminal provisions deemed to
be commerce related that have been enacted since the Civil War. A significant portion of
these laws were created after 1970.4 Despite the large increase in the number of federal
laws, the federal government plays a very small role in persecuting individuals for
breaking laws. Federal prosecutions are estimated to make up about five percent of
prosecutions across the nation.5 Some believe the federal government appears to be
selective with the cases they do prosecute. They assert that the rate of federal
prosecutions is not a realistic way to control crime and that these prosecutions serve more
as political statements.
When the founders created the Constitution they gave police power to the nation
specifically to combat the areas of counterfeiting, piracies, military crimes and treason.6
These crimes are understandably within the interest of the federal government because
they directly affect the federal government or its institutions.
Federal power had gradually been expanded to prevent abuse of the mail service
and for regulation of commerce between states.7 Initially, in the beginning Congresses’
expansion of power through the Commerce Clause was guarded by the Supreme Court.
Since 1939, its view of Congresses’ power had become more generous and federal power
has grown exponentially. The drastic increase in federal criminal legislation has
consequently also led to a large increase in federal litigation.8 The growth of federal
responsibility has directly led to a significant rise in the amount of resources the federal
4

Newbern, “Good Cop Bad Cop,” 1581.
Ibid.
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government consumes. The increase in expenditures by the federal justice system
doubled that of state and local judiciary expenditures between 1980 and 1990.9 The
American Bar Association Task Force on Federalization of Criminal Law asserted that
attempts by the federal government to decrease the rate of national crime by federally
prosecuting criminals has unintentionally decreased the effectiveness of local law
enforcement. The task force concluded that the costs of increased federalization outweigh
the benefits.10
This federal expansion of power comes directly from the Supreme Court’s
interpretation of the Commerce Clause. From the drafting of the Constitution until the
Civil War, the Supreme Court ensured that criminal law was seen exclusively as the
jurisdiction of state governments11 The Supreme Court’s rulings on the limitations of the
federal government’s power over state government in this time period was much more
restrictive than in the post-Civil War era.
The first significant conflict involving federal power through the Commerce
Clause came when President Roosevelt used the power of the Commerce Clause to
implement New Deal legislation. In cases like A.L.A Schechter Poultry Corporation v.
United States and Carter v. Carter Coal the Court countered the federal government’s
jurisdiction maintaining that local economic activity would only be within the reach the

9
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federal government’s regulation if it were to directly have an effect on interstate
commerce.12
However after Roosevelt’s “court packing” there was a shift in the Supreme
Courts Commerce Clause interpretation.13 In NLRB v. Jones and Laughlin Steel Corp, the
Court decided to uphold the National Labor Relations Act of 1935, which prevented
Jones and Laughlin Steel from firing employees on the basis of union organizing. This
decision essentially overruled the previous two cases. The Supreme Court found that
“although activities may be intrastate in character when separately considered, they have
such a close and substantial relation to interstate commerce that their control is essential
or appropriate.”14
The courts expanded on this interpretation of Federal power under the Commerce
Clause even further in the case of Wickard v. Filaburn. The Court ruled that a famer’s
production of wheat is not permitted to be in excess of the Agricultural Adjustment Act
of 1938, even if the farmer had had grown the wheat for himself. The Supreme Court
found that Filaburn’s “own contribution to the demand for wheat may be trivial by itself,”
but it was “not enough to remove him from the scope of federal regulation where …his
contribution, taken together with that of many others…[who are] similarly situated, is far
from trivial.”15 The Court also asserted that by growing his own wheat, Filaburn was
removing himself from the market and obstructing the Act’s purpose of stimulating trade.
This case affirms that Congress has authority over personal and local affairs if the
12
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person’s conduct multiplied would influence interstate commerce. The reach of federal
power through the Commerce Clause was expanded again when the United States
encountered the Civil Rights era court cases. In many of these cases, the Supreme Court
affirmed Congresses’ power by indirectly relating each case to intrastate commerce.
One of the most important cases was Perez v. United States, where the Court
upheld the Consumer Credit Protection Act which was created to prohibit loan sharking
activities and to counter organized crime. The Court found that “extortionate credit
transactions, though purely intrastate, may… affect interstate commerce.”16 This is
important because it implies that “even if a single, interstate instance of crime was too
insubstantial to merit federal jurisdiction, the Court held that if the type of crime could be
categorized as a national problem then the effects of individual instances of that type of
crime, in aggregate, merited Congressional attention.”17 Justice Stewart argued that with
this finding, anyone can be prosecuted federally for any crime. The Perez case cleared a
path for a multitude of federal criminal legislation, even if the crimes or their effects are
local in nature.
It wasn’t until the Lopez case that the federal government’s power under the
Commerce Clause was halted for the first time in sixty years.18In United States v. Lopez
the Supreme Court struck down the Gun-Free School Zones Act of 1990 from a section
of the Crime Control Act of 1990.19 The act made it a crime to bring a gun to school or a
place that the individual has reason to believe is a school. Alfonso Lopez, a young high
16
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school student, had done just that. Alfanzo was paid forty dollars to deliver a gun to
someone after school. He brought the gun and bullets to school but was caught by
officials.
Lopez was charged under Texas state law, but the state dropped all charges when
the Assistant U.S Attorney of the district decided to press federal charges on Lopez with
the Gun-Free School Zones Act. Lopez was convicted and sentenced to six months in
prison.20 Lopez appealed on the grounds that the Gun-Free School Zones Act was beyond
Congressional legal jurisdiction. The appeals court reversed his conviction. The court
found that as “broad as the commerce power is, its scope is not unlimited, particularly
where intrastate activities are concerned.”21
Congresses does have jurisdiction over any interstate channels of commerce,
interstate “commerce instrumentalities” and that which “substantially effects interstate
commerce.”22 The Court expressed concern over a “general police power of the sort
retained by the States.”23 Many were surprised by this monumental court case because it
put a stop to a half century of nearly unrestricted congressional jurisdiction. The case was
soon reaffirmed by United States v. Morrison.
United States v. Morrison was about a woman who was raped by two men. After
raping her, the men verbally abused her with derogatory sexist remarks. The men were
federally prosecuted under the Violence Against Women Act of 1994. The Court found
that the Violence Against Women Act exceeded the jurisdiction of Congress. The Court
20
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came to the conclusion that violent gender-motivated crimes are not economic in nature
and have no relation to interstate commerce.
The courts made it clear with these two cases that Congress could not continue
general policing powers that overlap state powers. The reaffirmation of the Court’s stance
on the Commerce Clause with Morrison establishes that concrete evidence of an
economic interstate connection is necessary for Congress to federally prosecute
individuals.
This decision also marks a change of direction in the Court to a new form of
federalism and it represents a shift in favor of state autonomy and limitation of federal
power. This shift has received some criticism, particularly from Justice Souter. Justice
Souter expressed concern that this new direction “does not properly account for the
interdependent nature of modern commerce.”24 This change in the Court’s view of
federal power was again supported in Alden v. Maine. In this case, the Court highlighted
the lack of Congresses’ authority under Article I to “subject non-consenting States to
private suits for damages in state courts.”25 These court cases in addition to others have
indicated a shift to support state control over functions that traditionally belong to the
state.26
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Chapter 3
Joint Priorities: Federalism and Individual Rights
The Lopez and Morrison court cases give insight into a direction that should be
pursued for the proponents of medical marijuana. It is most common that individuals who
make arguments in favor of medical marijuana pursue the individual rights argument.
Many find it to be more satisfying to directly argue for and peruse greater individual
rights but it may be more effective for advocates to follow Lopez and question the reach
of the CSA. If they were to question congressional authority under the Commerce Clause
to regulate medical marijuana, they might be able to stop the federal government from
interfering.
After California started the movement to stray from federal policy with medical
marijuana initiatives, many other states began to join. The increase in the number of
states with medical marijuana legislation resulted in a rise in legal cases to test the new
laws. The federal government began to threaten physicians with the revoking of licenses
for those who planned to follow California’s state law.1 With the aid of two non-profits, a
group of patients and physicians filed a case in the U.S. District Court for the Northern
District of California in 1997. In Conant v. McCaffery, the plaintiffs sued on the grounds
that their First Amendment rights were being infringed upon because the restriction of
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physician-recommended marijuana breached doctor-patient confidentiality. The court
found that the federal government cannot prevent physicians from merely recommending
marijuana.2 The court also found that the government was overly broad in its policy. It
held that while the government can control the regulation and distribution of drugs, it
cannot prevent speech about those drugs. The court did note that that if this speech was
intertwined with criminal conduct or if the physician used speech that was criminal in
nature such as conspiracy, than it is within the government’s power to regulate it.3 In a
footnote of the ruling the fears of the government were found to be exaggerated because
the court found it unreasonable to believe that the use of medical marijuana by a small
portion of the population would affect interstate drug trade.4 This note leads many to
speculate that the Court would not allow federal prosecution of individuals for medical
marijuana on the grounds that it does not fall within international commerce or the
regulatory power of Congress.
In 1994 a women was apprehended with two pounds of marijuana that she
claimed was for the treatment of her migraine headaches and religious purposes. The
Court dismissed the religious reasoning but considered the idea that it was necessary for
medical purposes, and the Court allowed the woman to apply a medical argument to her
case.5 The Court found that the quantity being transported did not qualify for a medical
defense under the Compassionate Use Act. The Court found that “if the quantity
transported and the method, timing and distance of the transportation are reasonably
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related to the patient’s current medical needs,” then it might qualify for the
Compassionate Use Act. Even though the Compassionate Use Act does not provide for
any transportation of marijuana the Court considered it a legal possibility if the
conditions are appropriate.
Another critical case was People v. Peron. This case also had to do with the issue
of the sale and possession of marijuana for medical use. The Court found that the sale and
possession of marijuana was not permitted even if it was not for profit, and that the
Compassionate Use Act only protected individuals for simple possession and cultivation
of marijuana. In turn, the Court ruled that many of the states’ cannabis clubs did not
qualify as authorized as primary care givers and were not exempt under the state statute
for possession or cultivation of marijuana. The Court took issue with the loose definition
of “primary caregiver.” It made the point that any drug dealer could become a primary
care giver under this argument.6 The Court did note that its ruling should not stop an
actual primary caregiver from producing and distributing marijuana. This should
presumably be taken as a hint that transactions of marijuana between patient and
caregiver without money will not be within the congresses jurisdiction under the
Commerce Clause.
Another case that gave insight into the reach of federal power was United States
v. Cannabis Cultivators Club. This conflict occurred when federal marshals started
closing down cannabis clubs which patients had been using to acquire their medical
marijuana. A preliminary injunction was filed by the federal government to close down
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the San Francisco Cannabis Cultivators Club. The United States District Court of the
Northern District of California ruled in favor of the prosecution in May 1998.7 The Court
based this decision on the legal legitimacy of the club to distribute marijuana rather than
the patient’s right to use the drug.
The Court concluded that just because a drug is grown for medical use doesn’t
make it any less part of a national drug market. The Court distinguished this case from
Lopez by highlighting the fact that Lopez was merely possessing a gun whereas the Club
was distributing marijuana, thus making it a commercial activity within the jurisdiction of
the Commerce Clause.
Despite the fact that no concrete evidence had been used to prove that marijuana
had been engaged in interstate travel or made an impact on the national market, the Court
held it had an impact on the national market. Some believe that this case was dismissed
because it was a preliminary injunction and because the case dealt primarily with
distribution.8
The next major court activity involved a motion in February 1999 by the Oakland
Cannabis Collectors Club to stop the federal government from enforcing the Controlled
Substance Act. The district court dismissed the motion on the grounds that plaintiffs can’t
get marijuana from a buyer’s club.9 Some speculate that the court did not rule on whether
the plaintiffs could grow marijuana they had used on their own because it was out of
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federal jurisdiction under the Commerce Clause.10 It would seem as though the Court’s
power should be saved for the rights of individuals where its purpose is best served.
Some find it to be more comfortable to avoid the “liberal paradox,” or being in the
strange position of arguing for less federal control over states’ rights when historically
states tried to fight the federal government for their rights in order to maintain racist
laws.11
One direction that the individual rights argument has gone with medical
marijuana is a claim to equal rights. The federal government, through the Controlled
Substance Act prohibits all marijuana use including medical purposes. However, the
federal government provides eight very ill patients with marijuana. This violates the
Equal Protection Clause that all persons should be treated equally. If two patients with
similar or identical medical conditions are given unequal treatment by the state, it is
possible to argue a “substantive due process claim” which would “contend that plaintiffs
have been denied a fundamental liberty interest” or possibly even “the right to effective
medical treatment.”12
It is worthy to note that courts have been hesitant to accept medical treatment as a
fundamental right. It had been recognized as so in the context of abortion but some
perceive a change in this view over the years.13 If medical marijuana were to qualify as
an infringement of equal protection or due process claims, then the rationale behind this
would be reviewed and scrutinized heavily.
10
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One such court case of equal protection claim came from a drug called Laetrile. It
was made from the pits of apricots. Proponents of the drug claimed that if it was taken in
very high doses in coordination with a special diet it would slow the growth of cancer.
The medical community condemned this drug as illegitimate medicine and it was banned
by the FDA. The FDA asserted that the medication failed effectiveness and safety
standards. Shortly after, twenty-two states went against the FDA’s ban on the drug by
making the sale of it legal within their state boundaries. The issue came to the Supreme
Court in United States v. Rutherford when patients and physicians brought a suit to stop
the FDA from banning Laetrile’s distribution. At first they argued that an exception
should be made and terminally ill patients should be allowed access to the drug. They
based this argument on their belief that federal interference with a person’s ability to
access the drug was an invasion of their right to privacy.14
Justice Marshall wrote that judicial deference was “particularly appropriate,”
because of considerable public controversy surrounding this drug, and because the
authority for new drug approvals resided with the FDA.15 The Court also held that
exceptions couldn’t be made based on the extent of a patient’s illness, but that patients
should be protected from “fraudulent cures not recognized by the FDA.”16
In Carnohan v. United States another plaintiff was trying to prevent the FDA
from interfering with his right to access Laetrile. The Court found that “constitutional
rights of privacy and personal liberty do not give individuals the rights to obtain Laetrile
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free of the lawful exercise of government police power.”17 In Cannabis Cultivators Club
II, the district echoed the Carnohan finding that the plaintiffs had no fundamental right to
have the medicine of their choice.18 This ruling ended the plausibility of an argument for
medical marijuana under the Equal Protection Clause.
An equal protection argument was used in 1996 by Ralph Seely who asserted that
the classification of marijuana as Schedule I was in violation of his protection of equal
rights under the Constitution of Washington.19 Seely had bone cancer and smoked
marijuana to reduce the nausea and vomiting. The Court found that he had no fewer
rights under the state Constitution than he did under the U.S Constitution.
Another person made the individual rights argument in an attempt to gain the
right to be admitted to the Federal Compassionate Use Program. In Kuromiya v. United
States, Kuromiya made the argument that he was not given equal protection because the
federal government was providing a small number of individuals with medical marijuana
but was refusing to admit Kuromiya into the program and provide equal treatment.
The Court found that the Federal government had the right to address problems in
parts and therefore did not have to allow all patients to receive medical marijuana.20 The
Court also acknowledged that the federal government had decided to shut the program
down for various reasons. However, the Court condemned the federal government for not
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having produced “a single useful clinical result as to the utility or safety of marijuana as a
medicine.”21
It is important to note that in the case of the Oakland Cannabis Buyers’
Cooperative, the Unite States Court of Appeals for the Ninth Circuit Court remanded the
district court for a preliminary injunction that prevented the Oakland Cannabis Buyers’
Club from the distribution of medical marijuana during the legal proceedings.
The Ninth Circuit objected to the fact that the district court had failed to consider
a defense based off medical necessity. Under this defense, clubs could distribute
marijuana to patients whose physicians certify that they:
“(1) suffer from a serious medical condition, (2) will suffer imminent harm
without access to cannabis, (3) need cannabis for the treatment of a medical condition or
alleviation of symptoms associated with a condition, or alleviation of symptoms
associated with a condition, and (4) have no legal alternative of the effective treatment of
the condition because the patient has tried other legal alternatives for the effective
treatment of the condition because the patient has tried other legal alternatives and found
them ineffective.”22
The Ninth Circuit court found no particular reason for the injunction to be
necessary because if they would have just prosecuted the defendants under the current
drug laws the defendants would have been able to use a medical necessity defense. This
case does show that the Ninth Circuit court does place a larger emphasis on considering
patient medical necessity but it is still very difficult to win a medical necessity defense
case.
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This is shown in the case of McCormick and McWilliams in the United States
District Court for the Southern District of California. In the Case McCormick who suffers
from bone cancer, and Peter McWilliams, who suffers from AIDS were facing Federal
drug charges in the Los Angeles district court. On November 5, 1999, the U.S District
Court Judge George King prevented the two defendants from testifying their medical
condition, or the passage of Proposition 215 because he found that such testimony would
be irrelevant.23 The patients are unable to testify their debilitating nausea or excruciating
pain. The patients essentially had their hands tied behind their back and would no longer
be able to present a necessity defense.
They were tried like ordinary criminals. This case has very important implications
for medical marijuana legalization. In order for a patients defense to work the federal
government’s ability to prosecute individuals without medical consideration needs to be
halted. One of the most plausible ways to do this would be through an attack on
congressional authority using Lopez based argument on the Commerce Clause.
It is important to note that these cases reveal a trend that the majority of justices
are looking at the future with a renowned sense of federalism. In the cases of Lopez and
Morrison, it is important to acknowledge the Justices changing view of individual rights.
Both of these cases affirm that the Supreme Court does not agree with the broad
scope of power the federal government has been granted in the past. The Court is looking
to make sure that federalism is not hindered. It is unlikely that any court will strike down
the CSA but Lopez does affirm the significance and necessity of a fundamental
23

Newbern, “Good Cop Bad Cop,” 1598.

30

co
onnection beetween mediical marijuan
na and intersstate commeerce. It is veery likely thaat
feederal regulaation will be limited to Ju
ustice Thom
mas’s view off Congress ppower underr the
CSA
C
being ab
ble to “regullate the buyin
ng, selling aand transportting” of mariijuana , but
co
ongress lack
ks the power to “regulatee the mere poossession or use of marijjuana.”24 Unnder
th
his view it ap
ppears as tho
ough people who have a small amouunt of marijuuana may be able
to
o get out of federal
f
proseecution. Thiss means thatt medical maarijuana patieents may be free
frrom prosecution if they have
h
a smalll amount. Hoowever, the state program
ms are still iin
jeeopardy becaause the clin
nics and dispensaries thatt many patieents rely on aare within
feederal jurisd
diction. Sincee the federal governmentt views any large scale m
marijuana
movement,
m
medical
m
or no
ot as criminaal drug trafficcking, the faacilities whicch provide foor
th
he patients will
w most likeely remain taargets of the federal govvernment.

24

Newbern, “Go
ood Cop Bad Cop,”
C
1630.

Chapter 4
Homegrown Reeform: Congressional Attempts to Reform Medical Marijuana
There has been a significant amount of legislation through Congress over the
years relating to the legal standing of medical marijuana. The 105 Congress in
September of 1998 passed H.J.Res.117. The resolution supported the federal drug
approval process and prohibited the legalization of any Schedule I drugs for medicinal
use “without valid scientific evidence or approval from the FDA.”1 Congress also
amended the Act to prevent the District of Columbia from counting the ballots from its
initiative vote on the legalization of medical marijuana for persons with serious diseases
like cancer and HIV. This amendment was challenged in the District Court and
overturned. The ballots were counted with a strong victory of sixty-nine percent to thirtyone percent.
There are many other court challenges where Congress tried to inhibit the
implementation of medical marijuana legislation. One such example is when Congress
tried “to prohibit implementation of the initiative until the rider known as the Barr
Amendment was dropped from the FY2010 D.C appropriations act (H.R. 3288) in the
111 Congress.”2
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In the 108 session of Congress, a bipartisan bill was offered by Representatives
Hinchey and Rohrabacher. It proposed an amendment for H.R. 2799 that was designed to
prevent the Justice Department from using funds to intervene in the implementation of
state medical marijuana laws.3
The bill was debated on the 22 of July 2003 on the floor of the House but it was
defeated the next day in a vote of 152 to 273.4 It was offered up again in the 108
congresses second session on July 7, 2004 but it was defeated with the same results. The
amendment was offered up three more times in each consecutive congressional session
but it never came closer than 49 votes short of passing. During the debates the opponents
of the bill argued that medical marijuana has not been proven safe or effective and that
approval of this bill would “send the wrong message to young people.”5
In the 110 Congress there was an amendment (S. 1082) offered by Senator
Coburn that was designed to stop the state medical marijuana programs. It was adopted in
an 11-9 vote. The amendment basically reaffirmed that medical marijuana would be fully
subject to the FDA approval. However this amendment was not included in H.R. 2900
the version that was approved by Congress and enacted into law.
Also in the 110 Congress’s second session Representative Frank advanced H.R.
5842 an amendment called the Medical Marijuana Patient Protection Act.6 The bill was
created to provide federal legitimacy to the medical use of marijuana in accordance with
the laws of the states. The bill would have changed the status of marijuana form Schedule
3
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I to Schedule II on the Controlled Substance act. This would have given marijuana
medical legitimacy while maintaining its status as controlled substance for those who do
not have a prescription. It also would have permitted states with medical marijuana
programs to legitimize a physician’s ability to prescribe or recommend marijuana for
medical use.7 The bill permitted authorized patients who reside within states that permit
it, to possess, obtain, manufacture, transport or use marijuana.8 It allowed for authorized
individuals and pharmacies to distribute marijuana to authorized patients.9 The bill also
would have prevented any other act or agency from interfering with the state’s ability to
run the medical marijuana programs they had legally put into place.
The bill was “referred to the House Committee on Energy and Commerce and
saw no further action.”10 This legislation is not the first that was created in an attempt to
legitimize the medical marijuana programs in states. Versions have been seen in every
congress since 1997, but this one was seen by many as the most legitimate attempt to
decriminalize state medical marijuana programs.11
Another bill called the Truth in Trials Act (H.R. 3939), was introduced on the
October 27, 2009 by Representative Sam Farr. This bill was intended make it okay for
medical marijuana users or providers to reveal to the juries of federal courts that their
marijuana related activity is medical in nature and legal under state laws.
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During and after the 2001 Supreme Court decision U.S v. Oakland Buyers’
Cooperative, it was no longer permitted for individuals to reveal the legal status or
medical nature of their marijuana related activities. This would have allowed individuals
like McCormick and McWilliams to reveal their grave illnesses as well as the legal status
of their activity in their state and apply the medical necessity defense. The bill also would
have placed limitations on the federal agent’s abilities to confiscate marijuana which has
been authorized for medicinal purposes under state law.12 It would return any plants that
have been seized for pending cases. This bill was “referred to the Committee on the
Judiciary and also to the Committee on Energy and Commerce.”13
Even though Congress has remained significantly opposed to recognizing
marijuana medicinally, there have been several pieces of litigation passed through
Congress since the beginning of state-run medical marijuana programs. Some of this
legislation has attempted to reform federal opposition medical marijuana.
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Chapter 5
Blazing New Trails: California Strays from the Federal Position
Since voters passed Proposition 215 in California, the implementation of this
program has been anything but smooth. Not only has the federal government fought its
implementation at every level but this program has seen local resistance as well. For the
purpose of this analysis, the medical marijuana program of California will be reviewed
because it has been at the front of the battle for medical marijuana. It has been leading the
way with the most liberal medical marijuana laws, a booming multi-billion dollar
marijuana industry as well as some of the most stringent federal and local resistance.
On November 5 1996, fifty-six percent of voters approved the California
Compassionate Use Act of 1996, also known as Proposition 215.1 The day after the law
took effect. Criminal penalties for “medical marijuana use, possession and cultivation by
patients with the written or oral recommendation or approval of a physician who has
determined that a patient’s health would benefit from medical marijuana” were now
legally protected from state prosecution.2 The Compassionate Use Act would be different
from the legislation many other states would pass later on because it allowed marijuana
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for the treatment of AIDS, cancer, anorexia, spasticity, chronic pain, arthritis, glaucoma,
migraines or “any other illness for which marijuana provides relief.”3
The last part is one of the most important parts of this proposition because it fails
to designate which illnesses do not qualify for medical marijuana. This theoretically
makes medical marijuana available to anyone with any ailment that a physician deems
would benefit from medical marijuana. This part makes the program more controversial
because it allows for the treatment of illnesses beyond the scope of scientific studies done
on marijuana and its effects as a treatment for specific medical conditions.
This part of the act is one of the reasons California’s medical marijuana laws are
the most liberal and is also part of the reason the implementation of California’s medical
marijuana program has received so much scrutiny. In addition to the nonspecific
definition of who qualifies, the act is also open-ended about how much marijuana patients
can possess stating that a patient can possess an amount “sufficient for the patient’s
personal medical purposes.”4
After this legislation was passed some groups made attempts to test the waters of
this new bill and create facilities to dispense marijuana to patients despite the federal
position that marijuana was still illegal under the Controlled Substance Act. This was
tested in People v. Peron and in United States v. Oakland Cannabis Buyer’s Cooperative
where the courts ruled that medical marijuana clubs did not count as primary caregivers
despite the fact that they were not for profit.
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In 2003 a bill was passed by the California State Senate titled Senate Bill 420 that
effectively clarified and created a system for medical marijuana distribution centers to
function under with more legal clarity. This bill specifically required the State
Department of Health Services to create and maintain a system which would issue I.D.
cards to qualified patients and it also established crimes surrounding the system to
maintain its legitimacy and prevent any fraudulent access to marijuana by illegitimate
patients. The bill aimed to “promote unified and consistent application of the Act among
counties within the state” and with local law enforcement officers.5
The bill authorized the Attorney General to “recommend modifications to the
possession or cultivation limits set forth in the bill.6 It also gave him power over the
security and prevention of marijuana being used outside its intended medicinal realm.
This bill was important to implement some security and clarification over the
ambiguity of Proposition 215 because as the courts stated in their ruling of People v.
Peron, there is little distinction between a medical marijuana caregiver and the average
drug dealer under the limited regulations.7 Despite the improvements made to proposition
215 with Senate Bill 420 there was still a lot of confusion of how the caregivers,
dispensaries and collectives would be able to operate since they were technically
categorized as drug dealers under Federal law.
Since the Federal government and the courts established in People v. Perez, that
the federal government did not distinguish between medical marijuana transactions that
5
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involved cash or no cash there was little incentives for the dispensaries to not make a
profit off their activities. Many in the medical marijuana industry continued to operate as
dispensaries that essentially sold marijuana in exchange for cash as permitted by state law
under Proposition 215.
Early on some cities accepted or embraced the passage of these laws and
the implementation of the medical marijuana program and actively created city ordinance
to regulate the growth of dispensaries in their cities. In Oakland, city leaders quickly
implemented regulations to control the number and location of dispensaries.8 In Berkley
the number of dispensaries was limited to three. In San Francisco, officials went so far as
to place the authority of regulating dispensaries under the Department of Public Health
and gave them the power to enforce the handling of edible marijuana medication.9
Regulation in cities that took the initiative to establish it was well managed and there
since has been relatively little dispute between the local governments and the dispensaries
which provide for the patients.
In contrast, other cities that failed to recognize their legitimacy let alone regulate
their existence were quickly over run with dispensaries. The City of Los Angeles has
chosen to fight the legitimacy of marijuana dispensaries albeit unsuccessfully, and
because of inaction, had created a regulation vacuum in which 600 to 800 medical
marijuana dispensaries had opened from 2007 to 2011 with little oversight.10 According
L.A. city council man Paul Krekorian there are more medical marijuana dispensaries in
8
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Los Angeles then there are Starbucks coffee shops.11 Los Angeles City now is unable to
regulate these dispensaries because of lawsuits.
Some counties have taken measures to try and discourage the implementation of
the state mandated Medical Marijuana I.D. card program mandated by Senate Bill 420. In
2006, San Diego filed suit against the state of California on the grounds that the state
mandated program is in violation of federal law. The San Diego Superior Court and the
Fourth District Court of Appeals both ruled in favor of the State Mandate.12 The trial
court asserted that “Counties have standing to challenge only those limited provisions of
the MMP that impose specific obligations on counties.” 13 The court also wrote that
counties can’t directly attack legislation that does not directly impose obligations that
“inflict any particularized injury to Counties.”14 The court also wrote in its opinion that
the medical marijuana program provisions do not “positively conflict with the CSA,” and
that further “obstacles” are not posed to the CSA from the provisions that exempt
prosecution under California law.
When San Diego appealed to the Supreme Court in San Diego v. State of
California 2008, the Supreme Court refused to review the case and reaffirmed the lower
court decisions. The medical marijuana advocacy group Americans for Safe Access
(ASA) claimed that, “No longer will local officials be able to hide behind federal law and
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resist upholding California’s medical marijuana law.”15 This ruling affirms that the
Supreme Court has taken the stance that local government must obey this state mandate.
This would mean that all of the 9 other counties who had failed to permit the
implementation of this program would have to comply or face lawsuit.16 Despite the
Courts support for the identification program, the legitimacy of the program was
challenged again by the city of Garden Grove.
In the case of City of Garden Grove v. Superior Court a traffic stop by the Garden
Grove police department resulted in the confiscation of a third of an ounce of marijuana
from Felix Kha. When Feliz Kha challenged this in trial court with approval from his
doctor to use medical marijuana the prosecutor dropped the charges and the trial court
granted a motion by Kha to return his property and “ordered the Garden Grove Police
Department to give him back his marijuana.”17 This ruling shows the courts
acknowledge the legitimacy of California’s medical marijuana laws and their jurisdiction
over local authorities. The courts also acknowledged the legitimacy of the protection of
the patient’s medicine under California law. However the confirmation of state
jurisdiction of state legislation over local government does not necessarily affirm the
legitimacy of the entirety of the medical marijuana program under the CSA. The federal
government has used a number of leverage points, to target the institutions that facility
the production or dispensing of medical marijuana.
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dispensaries that pay taxes have trouble operating because of U.S. tax law Section 280E.
This provision denies any deductions for businesses involved in the trafficking of
controlled substances. This means that medical marijuana dispensaries are forced to pay
taxes on their gross income instead of their net income. This can make it incredibly
difficult for medical marijuana dispensaries to stay afloat. However, there is a loophole
that has allowed many marijuana facilities to continue to operate.
Some dispensaries in addition to providing cannabis for medical marijuana
patients provide other medical marijuana services such as counseling, physical therapy
and other physician related services to specialize patient treatment. In the 2007 case
Californians Helping to Alleviate Medical Problems Inc. v. Commissioner, the U.S. Tax
Court ruled that marijuana is not tax deductible under Section 280E but the separate care
giving services provided by the dispensary are.20
These tax court rulings have important implications for how medical marijuana
dispensaries operate and are taxed. If only a small portion of the premises, let’s say ten
percent, is used to distribute marijuana, than ninety percent of the rent is federally tax
deductible.21 Despite the state’s position on the legitimacy of medical marijuana
dispensaries, paying state taxes for medical marijuana dispensaries is no less complicated
than paying federal taxes.
The legitimate portion of the medical marijuana industry has also struggled with
federal influence over the Board of Equalization. After the increase of medical marijuana
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dispensaries following 2003 Senate Bill 420, the State Board of Equalization upheld a
policy that it has and will continue to reject efforts by the medical marijuana facilities to
pay taxes because they did not view them as legitimate organizations. Specifically the
State Board of Equalization refused to issue sellers permits to medical marijuana facilities
which is required by state law for “the sale of tangible property.”22
As medical marijuana grew into a multi-million dollar industry the State Board of
Equalization changed its policy in October 2005 and started distributing permits to
businesses, “even if the only property being sold was illegal.”23 After this change in
policy more collectives and dispensaries began paying taxes.
In June 2007, the BOE officially put out a statement the medical marijuana is not
only taxable but is also not tax exempt as a prescription medication. This is particularly
interesting because normally “non-prescription medications are taxable in California.”24
In January 2010 The BOE released a follow up Special Notice notifying dispensaries that
failure to obtain sellers permit by those who make marijuana sales are “subject to interest
and penalty charges” as well as “an eight –year look-back period.”25 The notice also
informs those responsible for dispensaries that may have “prior tax liabilities,” that BOE
has programs to assist in paying tax liabilities.26 An additional third notice was sent out
on February 24, 2011 to address a tax dispute with a dispensary called the Berkeley
Patients Group, Inc.

22

Joint Fiscal Office. "Medical Marijuana Fee and Tax Report." N.p., 3 Feb. 2012. Web.
Ibid.
24
Ibid.
25
Special notice by State Board of Equalization titled Important Information for Sellers of Medical
Marijuana January 2010 www.boe.ca.gov accessed 11/25/12
26
Ibid.
23

44

The dispensary claimed that because their medical marijuana sales were classified
as medicine they should be exempt from sales tax. The notice informed California
dispensaries that “sales of medical marijuana do not meet the definition of a sale of
exempt medicine, and are therefore subject to tax.”27 The BOE stated that the case was
reviewed by the BOE board in a Sacramento meeting that week.
This decision primarily came from the BOE decision to classify medical
marijuana under Tax Code Section 6051 instead of a medicine. The BOE used the
premise that medical marijuana is not recognized under the federal government’s CSA as
medicine and should therefore be classified as tangible personal property. The BOE
News Release quoted BOE Chairman Horton saying, “The United States Supreme Court
has ruled that as a general matter, the unlawfulness of an activity does not prevent its
taxation,”28 The BOE then cited the 1994 case of Dep’t of Revenue of Montana v. Kurth
Ranch. The BOE stated that “Sales of illegal medical marijuana and illegal marijuana in
California are subject to tax.”29
The BOE has notably shifted its position on the collection of state taxes from
medical marijuana. It has been more willing to recognize the importance of the economic
functions of these business establishments and the tax revenue they produce. It is an
understandable position because medical marijuana has brought a considerable amount of
revenue to state and local governments who routinely struggle to balance their budgets. It
is estimated that after the 2007 notice distributed by the BOE somewhere between $58
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million and $105 million has been collected from the states five percent sales tax on
medical marijuana.30 Since the 2007 estimate medical marijuana has grown significantly
and some estimate California’s medical marijuana industry to be around one billion
dollars.31
These local taxes have generated millions of dollars for the city of L.A which
institutes a 5% city licensing fee and has seen out of control dispensary growth. Despite
the increased revenue the city council members have understandably seen this growth as
problematic. Los Angeles failure to regulate the growth of medical marijuana
dispensaries early has led to dispensaries on nearly every block. The council members of
L.A in a 14 to 0 vote have placed a ban on all the cities dispensaries.32 Unfortunately for
the council members of L.A this act seems little more than symbolic since voluntary
compliance with the ban is unlikely.
It also would be difficult for police to get the resources to shut down almost a
1,000 dispensaries. Overcoming the physical limitations of enforcing this new ban would
be arduous but the ban also faces serious legal challenges.
The city sent a letter to the dispensaries that on September 6 2012, which stated
that their businesses would be illegally operating against city ordinance. The letter
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threatened a punishment of $2,500 dollars and up to six months in jail for every day the
dispensary continued to operate.33
The Patient Care Alliance, Los Angeles, or PCA-LA, filed a lawsuit and was
seeking an injunction to stop what it viewed as “controversial ordinance.”34 The
ordinance of Los Angeles was created in response to the ruling of Pack v. Long Beach in
2010.
In this case the Court of Appeals of California ruled that the power of cities to
place regulations on dispensaries or collectives is invalidated by the preemptive powers
of federal law and the CSA. Specifically the Court stated that regulations are federally
preempted because “city ordinance, which permits and regulates medical marijuana
collectives rather than merely decriminalizing specific acts,” is in violation of the CSA.35
This ruling was appealed to the Supreme Court.
Based on this decision cities across the state took it upon themselves to outright
ban medical marijuana from their cities. Los Angeles was one of these cities. Long Beach
also decided to abandon its regulations and outright ban dispensaries from the city. In
response to Long Beach’s abandonment of its regulations to institute a ban, the Supreme
Court decided to toss the Pack v. City of Long Beach finding on August 21 2012.
This act by the Supreme Court has put the feasibility of City dispensary bans
based on the Pack v. City of Long Beach into question. Later this year the Supreme Court
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will view several other Appellate cases which might bring some resolution to the most
recent areas of dispute surrounding the legitimacy of dispensaries and the regulations
surrounding them.
One of these cases is City of Riverside v. Inland Empire Patient Health and
Wellness Center. The Supreme Court will have to decide whether to agree or disagree
with the ruling that cities can regulate dispensaries but cannot ban them. This decision
will affect the 50 counties and cities within California that have enacted dispensary
ordinances.36
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Chapter 6
Blunt Enforcement: The Federal Government Crackdown
Since the year 1968 there has only been one source of marijuana that scientists
can use for research. This marijuana is under very tight controls by the United States
federal government. It has been grown at the University of Mississippi with a contract
from the National Institute on Drug Abuse. The marijuana is extremely difficult to obtain
by scientist whose research is approved by the FDA.1 The researchers also have claimed
the product of research does not meet the quality desirable for research purposes and is
lacking in strain variety.2
This is not the case with other Schedule I drugs like heroin, LSD, and MDMA
which are provided legally by “private U.S laboratories” or easily imported from abroad
with federal permission, making marijuana the only Schedule I drug with a single federal
provider.3
Dr. Lyle Cracker, a professor of plant biology and director of the medical plant
program at Massachusetts at Amherst, applied to get a DEA license to cultivate some
research-grade cannabis. His application was filed under the Multidisciplinary
Association for Psychedelic Studies (MAPS). This is a nonprofit organization led by Dr.
Rick Doblin whose goal is to conduct drug research on marijuana of higher quality and to
1
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create proper conditions for a five year, five million dollar study to transform smoked or
vaporized marijuana into a FDA approved prescription medicine.4 The DEA at first
ignored this request until it was sued on the grounds of “unreasonable delay”.5 It then
rejected the application in December 2004 because it found the request to be not
consistent with public interest.6 This decision was appealed after nine days of researchers
testifying that their requests had been rejected making FDA research impossible.
On February 12 2007 a DEA administrative law judge Mary Ellen found the
research supply to be inadequate and ruled to give Dr. Craker the proposed research
facility. This was overturned by the DEA Deputy Administrator on the 7th of January
2009.7 The federal government has been heavily involved in resisting scientific
understanding of marijuana much more so than it has with heroin, LSD, MDMA and
other Schedule I drugs.
The federal government’s response to medical marijuana from the beginning of its
implementation in California has been strong, with regular raids on medical marijuana
facilities. The DEA raids became especially common in California because caregivers
can receive “reasonable compensation” and still be functioning on a non-profit basis.8
The DEA does not distinguish between medical marijuana operations and drug traffickers
so there are no official statistics on how many facilities get raided, but the DEA has
usually prioritized its raids on the high profile marijuana patients, cultivators and
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dispensers.9 These raids were common, but in general the medical marijuana industry was
surviving.
At the end of the Bush administration in 2007 the DEA stepped up its efforts with
a new tactic. The DEA Los Angeles Field Division in 2007 sent out letters to owners of
property being used to facilitate medical marijuana programs that they would be subject
to the “crack house statute.” This was provision added to the CSA in 1986 which made it
a federal offense for individuals to “knowingly and intentionally rent, lease, or make
available for use, with or without compensation, a building, room, or enclosure for the
purpose of unlawfully manufacturing, storing, distributing, or using a controlled
substance.”10 The DEA was threatening owners of property with a 20 year jail sentence,
seizure of property, and fines for facilitating anyone partaking in the medical marijuana
industry. These tactics have led to a series of lawsuits and legal battles.
Despite some of President Barack Obama’s campaign promises, the federal
prosecution of medical marijuana continued after his 2008 election. In March 2009, the
Attorney General Eric Holder made an announcement that the federal government under
the Obama administration would use its resources to target medical marijuana operations
that were not in compliance with state law. 11 This policy was formally embraced by the
Justice Department memorandum addressed to the U.S. Attorney on October 19, 2009.12
This became known as the Ogden Memo. It stated that federal resources should not be
prioritized for use in combating “individuals whose actions are in clear and unambiguous
9
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compliance with existing state laws providing for the medical use of marijuana.”13 This
announcement was quite remarkable because it showed that the federal government had
made a distinction between the states medical marijuana program and criminal
enterprises. Many believed that the Obama administration was fulfilling its campaign
promises and Federal government would be more flexible to the laws the state has
created.
However, the federal government abruptly changed its position again when
Obama re-nominated Michele Leonhard from the Bush administration to head the DEA.14
In the middle of January 2011 shortly after she was confirmed as head of the DEA, she
reignited the federal government’s war on the medical marijuana industry. The agency
released an updated version of “The DEA Position on Marijuana.” In this document the
DEA at first supports the position given by the Ogden Memo. However, the DEA then
follows this by stating “while some have interpreted these guidelines to mean that the
federal government has relaxed its policy on ‘medical’ marijuana, this in fact is not the
case.15 With this statement the DEA has confirmed it will continue raid medical
marijuana facilities and by placing quotes around ‘medical’ has confirmed that once
again the DEA does not view marijuana as having any medical purposes.
The position was escalated even further when prosecutors of the federal
government sent a letter to Gov. Christine Gregoire threatening legal action against state
employees stating, that they “would not be immune from liability under the controlled
13
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substance act.”16 The Federal government was essentially threatening state officials who
were trying to regulate the growing medical marijuana industry in their state with felony
criminal prosecution.
On June 29th, Eric Holder’s predecessor, James M. Cole released a memo
reinstating medical marijuana dispensaries as targets. The memo stated, “persons who are
in the business of cultivating, selling or distributing marijuana, and those who knowingly
facilitate such activities, are in violation of the Controlled Substances Act, regardless of
state law.”17 These actions by the federal government and its corresponding agencies
shows that the Obama administration has decided to reignite the war on medical
marijuana.
Some believed that this escalation in the war on medical marijuana was an
attempt from the Obama administration to win the approval of older voters in an election
year but the position has not been changed since Obama has been reelected in 2012. The
Obama administration has neither reprimanded nor fired any federal officials for the
crackdown on medical marijuana so it is very possible that this policy will hold until the
end of the Obama administration.
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Chapter 7
Policy Burnout: The Hazy Future of Medical Marijuana
With the recent crackdown of the Obama administration on medical marijuana it
is very possible that the federal government could choose to fight medical marijuana for
many years to come. Another factor that might affect this issue is that in Obamas first
four years, he elected Judges to the high court. In the next four years, if either of the two
seventy-six year old conservative justices steps down then Obama could make a real
impact on the courts.1 As long as the Federal government continues to recognize medical
marijuana as a Schedule I substance with no medical value the courts will play an
important role in medical marijuana’s future.
It is very possible that the Supreme Courts could return to their previous pre
Lopez/Morrison view of Federal Jurisdiction. It is also possible that the public’s opinion
of marijuana could change drastically. At the moment public opinion polls show that
Americans overwhelmingly approve of medical marijuana. In a 2011 poll seventy-seven
percent of the public approved of medical marijuana.2 However, it is possible that some
kind of incident with marijuana could tarnish public opinion of medical marijuana and
drastically effect the movement.
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These chances are enhanced because in the 2012 election, voters in Colorado and
Washington both passed initiatives legalizing marijuana for recreational use. Any adverse
factors resulting from the legalization movement could have negative impact on the
medical marijuana movement. Progress with medical marijuana has been very fluid with
a series of victories and setbacks for proponents of the movement. The future of this drug
as a medication still remains very uncertain.
After many years and battles between advocates and opponents of medical
marijuana the legal disputes have resembled that of a push and shove match between
federal state and local officials that has been expensive and has had many casualties.
Many are terminally ill people prosecuted to test the powers of regulation between
federal and local government. At the best these methods of establishing a legitimate
medication seem unconventional and at their worst uncivilized. This precarious process is
unfitting for a country that considers its self to be modern and progressive. A medication
should either be scientifically proven to work or not. Its use should be determined from
these scientifically tested facts. A countries’ federal government who refuses to conduct
scientific tests on a medication because of politics should reevaluate its purpose. A
government that discourages medical progression is clearly not acting within the best
interest of its people.
It is also regrettable that local and state governments are willing to disobey the
federal government and distribute a medication that is not fully tested or developed by the
proper agencies designed to ensure public safety. In effect local and state governments
have put their populations at risk.
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This process has also seen amateurish legislation that has led to poor restriction,
regulation, and distribution of this medication. In places like Los Angeles, regulation is
minimal and an individual can visit a physician with no previous medical records, pay the
physician a small fee and obtain medical marijuana card permitting access to most
medical marijuana dispensing facilities in the state. This kind of patient drug access is not
only questionable by professional medical standards but it is also a way for illegitimate
patients to access the drug.
The medical marijuana legislation of many states has ultimately failed to
distinguish between the legitimacy of seriously ill patients and recreational marijuana
users. Many of which have taken over the movement of these legitimate patients and their
providers who are merely trying to establish low key access to a medication.
In general the poor regulation of for-profit drug dispensing physicians has led to
the deaths of a lot of Americans. This concept is an example of the abhorrent monstrous
perversion of bad medicine that plagues America. If the residents of some states would
like marijuana legalized it should be done through a separate initiative without corrupting
safe scientifically supported medicine. The creation of this amateurish medical legislation
by states is a dangerous path and a slippery slope for the future of American medicine.
This poorly regulated industry has also provided the means for opportunists to
disguise highly profitable criminal activities. Others have been able to take advantage of
the plight of seriously ill patients to forward a political agenda of legalizing marijuana.
This has resulted in a movement that often appears to take the form of a backdoor effort
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to legalize marijuana and has been rather slow and unsuccessful in getting seriously ill
patients safe and proper treatment.
This fundamental failure of furthering scientifically based medical progression
has been at the expense of many terminally ill patients, legitimate physicians and law
abiding citizens trying to provide medicinal resources needed for seriously ill members of
their community. This process has taken almost three decades and has been very taxing in
both federal and local government resources.
The federal government is using its scarce resources to combat medical marijuana
so rigorously when it has had few if any documented fatalities.3 The United States
government census estimates the prescription pill industry from the period of 1995 to
2009 grew at a 250% increase from a $72 billion dollar industry to a $260 billion dollar
industry.4 These statistics are complemented with the Center for Disease Control and
Prevention statistics that prescription overdose rates have grown to approximately four
times the rate of 1970.5 The CDC estimated that out of the 27,000 unintentional drug
overdoses 14,000 are directly from the increase of narcotic painkillers.6
Dr. Thomas Frieden of the CDC stated that “prescription overdoses are epidemic
in the U.S.”7 Dr. Thomas also expressed concern over the growth of “pill mills.”
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Interestingly the prescription drug problem has mainly been combated more at the state
level than at the federal level. The CDC asserts that the best way to lower the death rate is
“enforcing existing laws” and the CDC also expressed concern that the laws are “not
enforced uniformly” with “only a few states having laws regulating for-profit clinics that
distribute controlled prescription drugs with minimal evaluation.”8 If the federal
government would have allowed science to determine medicine instead of politics this
long and expensive battle could have been avoided and there would most likely not be the
current semi-legitimate medical industry that has become so difficult to control. If
medical marijuana was legitimized or refuted with science the federal government would
be able to focus its scarce resources on the problems which are actually killing many
Americans.
It is particularly unsettling that the federal government has been reluctant to
scientifically test the medicinal value of marijuana while running its IND program
specifically implemented for this purpose. Many international and private studies have
been conducted on the medical value of marijuana.9 Its use has been endorsed by the
American Academy of Family Physicians, the American Public Health Association, the
American Nurses Association, the New England Journal of Medicine and The Lancet.10
There have been many commendable studies and evaluations by medical associations that
have suggested that there is recognizable medical value to cannabis.
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However, in principle it is important that any medicine be approved by the FDA
because safety and effectiveness is a fundamental priority of progressive medicine. The
FDA was created to ensure that this priority is met. The current FDA position is that
marijuana is not medicine. Decisions by the FDA should usually be supported. However,
in this instance their conduct has left many questions unanswered. This federally funded
agency has acted in a manner that lacks integrity and professionalism. This is evident in
the Supreme Court rebuking of the federal government, in the case of Kuromiya v. United
States, because of its failure to produce some credible research results after twenty-three
years of research in its IND program. To this day the federal government has not publicly
released credible research results and holds that marijuana is not medicine.
This lack of scientific research may be testament to the federal government’s
political opposition to marijuana and failure to pursue the advancement of medicine
supported by science. At times it appears that the Federal government has chosen to
jeopardize public safety by using vast resources in the pursuit of politics rather than
investing in a future of scientifically based medical advancement.
The medical marijuana industry we see today is a direct result of Federal political
opposition. The states have been forced to make back door medical legislation to serve
the interests of the seriously ill people in their communities. This back door method of
creating a legitimate medical industry has been fraught with all the problems associated
with semi-legal underground activities. The legitimate portion of medical marijuana
industry has now become infused with a movement for legalization and an undeniable
criminal element. The medical marijuana industry is the problem it is today because the

59

federal government refused to accommodate scientific research and establish a controlled
medical program.
It appears that the Federal government is now faced with an out of control
criminal industry, a presumably endless future of resource consuming court battles across
the nation and seriously ill people who have semi-legal medication. It might be time for
the federal government to reconsider its strategy. It is not too late for the federal
government to reform its IND program or even reform its stance on medical marijuana to
create a legitimate system for seriously ill patients.
The plight of some of these terminally ill people seeking medication is really
quite remarkable. Many have been federally prosecuted or fined in their efforts to help
themselves or others who are seriously ill; these people have been the casualties of poorly
functioning government policy.
These patients are people like Jimmy Montgomery, a paraplegic confined to a
wheelchair. Jimmy suffered from muscle spasms typically associated with paralysis.
Jimmy took the recommendation of his doctor to use marijuana to reduce this problem.
The police confiscated two ounces from the back pocket of his wheelchair. He was
charged with intent to sell because the officer testified that the amount was too large for
personal use. Jimmy was charged and sentenced to life in prison. This was eventually
reduced to ten years. Police also attempted to seize the home of Jimmy’s sixty-two year
old mother, of which Jimmy lived in. Jimmy lost a leg from an ulcerated bed sore he got
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from poor prison conditions in solitary confinement. He was released on medical parole
after public pressure from the community.11
Bryon Stamate was the seventy-three year old caregiver of Shirley Dorsey, who
suffered from crippling back pain. Byron was caught growing cannabis for Shirley at
their home. Bryon was sentenced to nine months in prison. Their home and $177,000 in
savings were seized. After she was pressured by law enforcement to testify against her
caregiver Shirley committed suicide. In her suicide not she wrote,
“They want to take our property, security and herbal medicine from us, even
though we have not caused harm to anyone. It is not fair or in the best interest of
the people of society. I will never testify against you or our right to our home. I
will not live in the streets without security and a place to sleep. I am old, tired and
ill, and I see no end to the harassment and pressures until they destroy us.”12
Shirley’s situation was rather drastic and unique but her misfortunes bring light to
the seriousness of medical marijuana prosecution. It is not “in the best interest of the
people” for the government to continue to waste federal resources persecuting individuals
for a drug which can be recommended by a physician yet is not properly researched.
There are many other patients who have gone through absurd ordeals. Many
patients have lost all of their money in expensive court battles and have faced serious
prosecution. Seriously ill people are getting caught between confusing and contradictory
laws.
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For the past forty-six years now the federal government has tightly controlled
research marijuana through NIDA, providing poor quality marijuana to a select few
researchers, which Dr. Craker alleges “just isn’t adequate.” 13 Dr. Craker the highly
qualified director of medicinal plant program at the University of Massachusetts at
Amherst, has been trying to break the federal government’s strict control since 2001.14
He has been trying to fight the federal government’s resistance to allow high
quality marijuana to be professionally studied by researchers. There are thousands of
strains of marijuana, each with unique effects and medical potential. The federal
government has been providing a low quality limited variety to a small number of
researchers. In 2011 at the age of seventy Dr. Craker has given up his legal battle with the
federal government. A disappointed Dr. Craker asserted that, “All we want to do is to
produce the material that medical doctors want to use for tests.”15
It is likely that federal government officials like Michele Leonhart, current head
of the DEA, will continue to prevent proper medical research. In June 2012 while
testifying before the House Judiciary Subcommittee on Crime, Terrorism, and Homeland
Security, Leonhart refused to admit that marijuana was less addictive or dangerous than
methamphetamine, cocaine or any of the other Schedule II drugs.16 She awkwardly
dodged a series of straight-forward questions asked by Rep. Jared Polis while holding
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that “All illegal drugs in Schedule I are addictive.”17 This failure to publically
acknowledge a difference between marijuana and other drugs is testament to the
difficulties facing future research and scientific understanding of marijuana. It is strange
that the federal government is so insistent on marijuana being placed in schedule I on the
premise of addictive qualities when such potent addictive drugs like Oxycodone, cocaine,
and methamphetamine reside in schedule II and are not as difficult to obtain for research.
Politicians like her will continue to assert that the public interest resides with their
professional motivations rather than with medical professionals like Dr. Craker who
wants to establish legitimate scientific research.
It is time for the federal government to cooperate and allow for the collection of
proper scientific data. If the research fails to show the medicinal value of marijuana then
it should no longer be prescribed as medicine. If it is found to have medicinal benefits the
government needs to stop disrupting medical progression and permit it to be properly
regulated like any other medicine. The current impasse is dangerous and expensive. It is
bad policy, bad medicine, and needs be resolved. Many people have been and continue
to be punished for taking poorly regulated semi-legal medication. The federal
government needs to answer to public concern and make a professional reassessment of
its policies. It is important that the plights of these seriously ill people are not forgotten.
The future of medicine needs to be practiced professionally by doctors without the
interference of politicians.
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This entire ordeal which has been battled in the name of public interest is
testament to the difficulties the American Government faces in avoiding inefficiency
while serving the public interest. This difficulty is predominantly due to a failure of
officials to serve the interests of the people over their political beliefs or motivations.
This inefficiency has shown that in principle, the American government can and will fail
its population in regards to ensuring that they are receiving proper health treatment based
on scientific facts instead of politics. In addition to providing semi legal medication,
wasting billions in government resources and aiding criminal activities, this long and
unorthodox process has done little more than reveal potentially reparable weakness in the
U.S Government’s ability to function efficiently in the interests of its people. This
medical marijuana legalization process should be concerning to those who wish for
progressive medicinal advancements based on scientific fact rather than political beliefs.
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